Parexel International Corporation (NASDAQ:PRXL) has introduced an RFID based solution for recording temperatures during drug transportation. Developed together with StoraEnso and Medixine, the system records temperatures with a smart package. Information is read using Medixine’s mobile RFID solution and data is sent to a Medixine server.
“Facing ever more complex clinical trials, biopharmaceutical companies are looking to gain greater efficiency through consistent delivery of trial-related supplies to multiple locations worldwide. This key advancement in temperature control for investigational medicines represents our commitment to ensure that clinical supplies and logistics become further streamlined, enabling our clients to reduce associated time and costs,” said Joe Avellone, M.D., Corporate Vice President, Clinical Research Services, PAREXEL.